Staff Scientist
Fred Hutchinson Cancer Center (Fred Hutch) | |||||||||
parental leave, paid holidays, sick time, tuition reimbursement
| |||||||||
United States, Washington, Seattle | |||||||||
1100 Fairview Avenue North (Show on map) | |||||||||
Jan 12, 2026 | |||||||||
|
Staff Scientist
Overview Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington. With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world's leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world's deadliest diseases and make life beyond cancer a reality. At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. A Staff Scientist position in the Nelson, Haffner, Li and Ha research groups located in the Human Biology Division and Computational Biology Program is available immediately. We have established a research team working with interdisciplinary collaborators who have expertise in genomics, genetics, pathology, experimental therapeutics, cancer biology, and clinical cancer research. We are seeking a highly motivated individual with experience in applying bench laboratory experimentation and computational and analytical approaches to the study genomics and epigenetics of cancer. The specific focus for this position involves developing assays using ctDNA/cfDNA in cancer diagnostics. Candidates who are excited about driving projects and participating in teams that develop and apply technologies for interrogating cancer genotypes and phenotypes through bioinformatics, data science, genomics, spatial biology and drug development are encouraged to apply. The position has a competitive salary with excellent benefits. Responsibilities The research projects and responsibilities for this Staff Scientist position include:
Conduct research independently as well as contribute to research being done by other team members.
Candidates with strong interest and/or expertise in any of these research areas are highly encouraged to apply
This position requires full-time onsite work at our South Lake Union campus in Seattle Qualifications MINIMUM QUALIFICATIONS:
PREFERRED QUALIFICATIONS:
To apply, please submit your application with the following:
The annual base salary range for this position is from $84,406 to $191,755, and pay offered will be based on experience and qualifications. Additional Information We are proud to be an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to Human Resources at hrops@fredhutch.org or by calling 206-667-4700. | |||||||||
parental leave, paid holidays, sick time, tuition reimbursement
Jan 12, 2026